InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
10
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Reumuth Mary, Chief Financial Officer. Director active across 2 companies, notably Kala Pharmaceuticals, Inc.. In total, 15 filings have been published. Split: 0 buy · 10 sells. Total volume traded: €105k. History available since 28 June 2021. The latest transaction was filed on 22 October 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Reumuth Mary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
32,230 shares@ US$0.8331.4% of flowCommon StockSEC:0001710969-25-000003:0
3,631 shares@ US$4.0124.9% of flowCommon StockSEC:0001415889-25-018320:0
2,850 shares@ US$3.7424.7% of flowCommon StockSEC:0001415889-25-015680:0
10,100 shares0Common StockSEC:0001415889-25-001059:0
4,163 shares@ US$4.7564.8% of flowCommon StockSEC:0001415889-24-018375:0
1,786 shares@ US$6.0935.2% of flowCommon StockSEC:0001415889-24-015224:0
4,600 shares0Common StockSEC:0001415889-24-000767:0
36,144 shares0Common StockSEC:0001415889-23-010285:0
14,736 sharesCommon StockSEC:0001415889-23-009136:0
9,525 shares0Common StockSEC:0001415889-23-000639:0
194 shares@ US$6.512.0% of flowCommon StockSEC:0001415889-22-010880:0
2,613 shares@ US$0.370.0059% mcap1.5% of flowCommon StockSEC:0001415889-22-007062:0
2,850 shares@ US$1.3010.3% of flowCommon StockSEC:0001415889-22-000405:0
9,449 shares@ US$1.8045.9% of flowCommon StockSEC:0001415889-21-005012:0
2,452 shares@ US$5.7737.1% of flowCommon StockSEC:0001415889-21-003259:0
15 of 15 declarations
About Reumuth Mary
Reumuth Mary is Directeur Financier at Kala Pharmaceuticals, Inc. and KALA BIO, Inc. She has made 15 filings in total, and across the recent sample of 15 filings between 2021-06-29 and 2025-10-24, the reported transactions are all sales for a total of EUR 105467.
